165 related articles for article (PubMed ID: 36674861)
1. C1QBP Mediates Breast Cancer Cell Proliferation and Growth via Multiple Potential Signalling Pathways.
Scully OJ; Shyamasundar S; Matsumoto K; Dheen ST; Yip GW; Bay BH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674861
[TBL] [Abstract][Full Text] [Related]
2. Interactome analysis reveals that C1QBP (complement component 1, q subcomponent binding protein) is associated with cancer cell chemotaxis and metastasis.
Zhang X; Zhang F; Guo L; Wang Y; Zhang P; Wang R; Zhang N; Chen R
Mol Cell Proteomics; 2013 Nov; 12(11):3199-209. PubMed ID: 23924515
[TBL] [Abstract][Full Text] [Related]
3. Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.
Scully OJ; Yu Y; Salim A; Thike AA; Yip GW; Baeg GH; Tan PH; Matsumoto K; Bay BH
Exp Biol Med (Maywood); 2015 Jul; 240(7):846-53. PubMed ID: 25573962
[TBL] [Abstract][Full Text] [Related]
4. The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death.
McGee AM; Douglas DL; Liang Y; Hyder SM; Baines CP
Cell Cycle; 2011 Dec; 10(23):4119-27. PubMed ID: 22101277
[TBL] [Abstract][Full Text] [Related]
5. Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers.
Matsumoto K; Bay BH
Curr Med Chem; 2021; 28(25):5048-5065. PubMed ID: 33390103
[TBL] [Abstract][Full Text] [Related]
6. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.
Shi H; Fang W; Liu M; Fu D
Int J Cancer; 2017 Oct; 141(7):1389-1401. PubMed ID: 28608366
[TBL] [Abstract][Full Text] [Related]
7. C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells.
Wang Y; Fu D; Su J; Chen Y; Qi C; Sun Y; Niu Y; Zhang N; Yue D
Sci Rep; 2017 Apr; 7(1):999. PubMed ID: 28428626
[TBL] [Abstract][Full Text] [Related]
8. High molecular weight fibroblast growth factor 2 induces apoptosis by interacting with complement component 1 Q subcomponent-binding protein in vitro.
Hong X; Yu Z; Chen Z; Jiang H; Niu Y; Huang Z
J Cell Biochem; 2018 Nov; 119(11):8807-8817. PubMed ID: 30159917
[TBL] [Abstract][Full Text] [Related]
9. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis.
Wang Y; Yue D; Xiao M; Qi C; Chen Y; Sun D; Zhang N; Chen R
J Proteome Res; 2015 Feb; 14(2):804-13. PubMed ID: 25497084
[TBL] [Abstract][Full Text] [Related]
10. [Expression of C1QBP gene and its correlation with drug resistance in human resistance choriocarcinoma cell line].
Shen X; Han B; Shen Y; Yang J; Ren T; Sha G; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):616-20. PubMed ID: 25354864
[TBL] [Abstract][Full Text] [Related]
11. Complement C1q binding protein regulates T cells' mitochondrial fitness to affect their survival, proliferation, and anti-tumor immune function.
Tian H; Wang G; Wang Q; Zhang B; Jiang G; Li H; Chai D; Fang L; Wang M; Zheng J
Cancer Sci; 2022 Mar; 113(3):875-890. PubMed ID: 34978120
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation.
Wang Z; Sun A; Yan A; Yao J; Huang H; Gao Z; Han T; Gu J; Li N; Wu H; Li K
Mol Cancer; 2022 Apr; 21(1):92. PubMed ID: 35366893
[TBL] [Abstract][Full Text] [Related]
13. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
Yue D; Wang Y; Sun Y; Niu Y; Chang C
Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
[TBL] [Abstract][Full Text] [Related]
14. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
16. C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation.
Wang Y; Liu S; Tian S; Du R; Lin T; Xiao X; Wang R; Chen R; Geng H; Subramanian S; Niu Y; Wang Y; Yue D
Int J Med Sci; 2022; 19(5):842-857. PubMed ID: 35693733
[No Abstract] [Full Text] [Related]
17. Hypoxia-Mediated Complement 1q Binding Protein Regulates Metastasis and Chemoresistance in Triple-Negative Breast Cancer and Modulates the PKC-NF-κB-VCAM-1 Signaling Pathway.
Wu H; Chu Y; Sun S; Li G; Xu S; Zhang X; Jiang Y; Gao S; Wang Q; Zhang J; Pang D
Front Cell Dev Biol; 2021; 9():607142. PubMed ID: 33708767
[TBL] [Abstract][Full Text] [Related]
18. Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers.
Saha SK; Kim KE; Islam SMR; Cho SG; Gil M
J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30991713
[TBL] [Abstract][Full Text] [Related]
19. C9-ALS-Associated Proline-Arginine Dipeptide Repeat Protein Induces Activation of NLRP3 Inflammasome of HMC3 Microglia Cells by Binding of Complement Component 1 Q Subcomponent-Binding Protein (C1QBP), and Syringin Prevents This Effect.
Fu RH; Tsai CW; Chiu SC; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ
Cells; 2022 Oct; 11(19):. PubMed ID: 36231090
[TBL] [Abstract][Full Text] [Related]
20. Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment.
Xie Z; Gao Y; Ho C; Li L; Jin C; Wang X; Zou C; Mao Y; Wang X; Li Q; Fu D; Zhang YF
Gut; 2022 Mar; 71(3):568-579. PubMed ID: 33827783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
